HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts.

Abstract
IL-1 and TNF induced concentration-related increases in the synthesis of factor B, C3, and IFN-beta 2/IL-6 in human skin fibroblasts. Effects of both stimuli were apparent with concentrations as low as 0.1 ng/ml and maximal responses were observed between 1 and 10 ng/ml; only for IL-1 induction of IFN-beta 2/IL-6 was there a further increase in response up to 100 ng/ml. For factor B and C3, maximal increases induced by IL-1 and TNF were similar: 119- and 109-fold for factor B and 15-fold and 11-fold for C3, respectively. Although both IL-1 and TNF increase synthesis of factor B and C3 in hepatocytes, the increases observed in fibroblasts were approximately 50- and 8-fold more for factor B and C3, respectively. Neither protein synthesis nor mRNA for IFN-beta 2/IL-6 was present in HepG2 cells either before or after stimulation with IL-1 or TNF. In contrast to the similarities between the effects of IL-1 and TNF on synthesis of factor B, C3, and IFN-beta 2/IL-6, only TNF increased synthesis of factor H. Because TNF induces membrane IL-1 in fibroblasts, it is possible to speculate that the effects of TNF on fibroblasts are due to induction of IL-1. An autocrine action of TNF through IL-1 is possible for TNF-induced synthesis of IFN-beta 2/IL-6, but the effects of TNF on synthesis of factor B, C3, and factor H indicated that TNF has effects on fibroblasts separate from IL-1. The effects of IL-1 and TNF on the synthesis of factor B and C3 in fibroblasts may be a part of an acute phase response occurring at a local level. However, the large responses in synthesis of factor B and C3 to IL-1 and TNF may suggest that factor B and C3 have a role, as yet undescribed, in tissues in addition to the role these proteins are known to play in inflammation.
AuthorsY Katz, R C Strunk
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 142 Issue 11 Pg. 3862-7 (Jun 01 1989) ISSN: 0022-1767 [Print] United States
PMID2523936 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CFH protein, human
  • Complement C3
  • Complement C3b Inactivator Proteins
  • Interleukin-1
  • Interleukin-6
  • Interleukins
  • Tumor Necrosis Factor-alpha
  • Dexamethasone
  • Complement Factor H
  • Interferon-gamma
  • Complement Factor B
Topics
  • Adult
  • Cell Line
  • Complement Activation (drug effects)
  • Complement C3 (genetics)
  • Complement C3b Inactivator Proteins (metabolism)
  • Complement Factor B (genetics)
  • Complement Factor H
  • Complement Pathway, Alternative (drug effects)
  • Dexamethasone (pharmacology)
  • Female
  • Fibroblasts (metabolism)
  • Gene Expression Regulation (drug effects)
  • Humans
  • Interferon-gamma (pharmacology)
  • Interleukin-1 (pharmacology)
  • Interleukin-6
  • Interleukins (genetics)
  • Kinetics
  • Male
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: